Drug
ansuvimab
Marketed as EBANGA.
Generic name
ansuvimab
Brand names
EBANGA
First FDA approval
2020-12-21
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761172 | EBANGA | 2020-12-21 | RIDGEBACK BIOTHERAPEUTICS |
Manufacturers
RIDGEBACK BIOTHERAPEUTICS
Frequently asked questions
When was ansuvimab FDA approved?
Earliest FDA approval on record: 2020-12-21.
What brand names are sold as ansuvimab?
EBANGA.
Sources
Appeal a ansuvimab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com